Atrial fibrillation(AF)is the most common arrhythmia in clinical practice,with over 37 million people affected worldwide.AF may have great impacts on patients'cardiac function,cognitive function,quality of life,increase the risk of stroke,and raise the cardiovascular mortality.Therefore,early prediction of AF is crucial for reducing the risk of AF-related complications,early intervention,and improving patient prognosis.With the rapid development of artificial intelligence(AI)technology,its application in the medical field,especially in cardiology,has increasingly attracted great attention.In recent years,numerous studies have utilized various AI tools to analyze vast amounts of medical data,including clinical information and imaging parameters,trying to predict the occurrence,progression,and complications of AF,thereby providing a basis for clinical decision-making.However,despite certain progress,current research still faces multiple challenges,such as data privacy,model interpretability,the accuracy and rationality of parameter selection,and the clinical operability and feasibility of data implementation.Therefore,we aim to review the latest researches of AI in AF prediction,analyze the current application status,and discuss the future development,in order to provide references and insights for further research in related fields.

Aim To study whether intravenous injec-tion of miR-129-3p mimetic(agomir)can resist bone loss caused by hind limb disuse,and to provide new i-deas for preventing bone loss in microgravity environ-ment.Methods Forty-eight C57BL/6J male mice were randomly divided into the control group(CON),tail suspension model group(TS),tail suspension+miR-129-3p agomir administration group(miRNA)and tail suspension+miR-129-3p negative sequence agomir control group(NC).The miRNA group was given 4 mg·kg-1 miR-129-3p agomir by intravenous injection into the medial canthus twice a week.The NC agomir group were consistent with those in the miR-129-3p agomir group,and the CON and TS groups were given only equal volumes of normal saline.After four weeks,all mice were sacrificed and samples were collected.Micro-CT scan of femur,three-point femur bending test,serum bone metabolism index detection,oxidative stress index detection and osteogenesis-related protein expression analysis in bone tissue were per-formed.Results After four weeks,the number of tra-becular bone in the TS group was significantly re-duced,and Tb.BMD,Tb.Th,Tb.N,Tb.BS/TV and Tb.BV/TV were significantly lower than those in the CON group(P＜0.01).While Tb.Sp TS group was significantly higher than the CON group(P＜0.05),the maximum load and flexural strength of the femur significantly decreased(P＜0.01),the content of ser-um bone formation index PINP was significantly lower than that of the CON group(P＜0.01),and the con-tent of bone resorption index CTX-I was significantly higher than that of the CON group(P＜0.01),the content of serum oxidative damage indexes 8-iso-PGF2α and 8-OHdG significantly increased(P＜0.01),and the expression of osteogenesis-related pro-teins in bone tissue markedly decreased(P＜0.01).However,the increase or decrease of all indexes in miRNA group was significantly lower than that in TS group.Conclusions miR-129-3p mimetic can signifi-cantly reduce bone loss caused by hind limb disuse.This experiment provides a new idea and method for preventing bone loss in microgravity environment.

Objective:To investigate the effects of long non-coding RNA 01694(LINC01694)regulating the microRNA-128-3p(miR-128-3p)/telomeric repeat binding factor 1(TERF1)axis on the malignant biological behaviors of prostate cancer(PC)cells.Methods:Cancer tissues and corresponding adjacent tissues from 20 PC patients undergoing surgery at the Department of Urology,Jingzhou Central Hospital,between January 2023 and January 2024 were collected.Human PC cell lines(PC-3,DU145,LNCaP,C4-2)and normal human prostate epithelial RWPE-1 cells were routinely cultured.LNCaP cells were transfected with sh-LINC01694,sh-NC,miR-128-3p inhibitor,inhibitor-NC,miR-128-3pmimics,pcDNA,and pcDNA-LINC01694 using Lipo6000? transfection reagent.Cells were divided into the following groups:Ctrl,sh-NC,sh-LINC01694,sh-LINC01694+NC inhibitor,sh-LINC01694+miR-128-3p inhibitor,pcDNA,and pcDNA LINC01694 groups.The mRNA expression of LINC01694,miR-128-3p,and TERF1 in PC tissues and cells,as well as LNCap cells in each group,was detected by qPCR.The protein expression of TERF1,caspase-3,cyclin D1,E-cadherin,and N-cadherin in LNCaP cells of each group was detected by WB method.Clone formation assay,flow cytometry,and Transwell chamber assay were applied to detect proliferation,apoptosis,migration,and invasion of LNCaP cells,respectively.Dual luciferase reporter gene assay,RNA pull-down assay,and RNA-binding protein immunoprecipitation(RIP)assay were applied to verify the targeting binding relationship between LINC01694 and miR-128-3p as well as between TERF1 and miR-128-3p.Nude mouse LNCaP cell xenograft experiment was conducted to assess the effect of LINC01694 knockdown on tumor growth.Results:LINC01694 was highly expressed in PC tissues and cells(all P<0.05).Knockdown of LINC01694 in LNCaP cells promoted the protein expression of miR-128-3p,caspase-3,and E-cadherin,inhibited the protein expression of LINC01694,TERF1,cyclin D1,and N-cadherin,reduced cell proliferation,migration,and invasion,and promoted apoptosis(all P<0.05).All these effects were partially reversed by the miR-128-3p inhibitor(all P<0.05).LINC01694 could directly bind to miR-128-3p(P<0.05),while miR-128-3p could directly bind to TERF1 mRNA(P<0.05),indicating that LINC01694 regulates the miR-128-3p/TERF1 axis.Knockdown of LINC01694 significantly inhibited the growth of LNCaP cell xenografts in nude mice(P<0.05).Conclusion:LINC01694 regulates the malignant biological behaviors of LNCaP cells through the miR-128-3p/TERF1 axis.

Atrial fibrillation(AF)is the most common arrhythmia in clinical practice,with over 37 million people affected worldwide.AF may have great impacts on patients'cardiac function,cognitive function,quality of life,increase the risk of stroke,and raise the cardiovascular mortality.Therefore,early prediction of AF is crucial for reducing the risk of AF-related complications,early intervention,and improving patient prognosis.With the rapid development of artificial intelligence(AI)technology,its application in the medical field,especially in cardiology,has increasingly attracted great attention.In recent years,numerous studies have utilized various AI tools to analyze vast amounts of medical data,including clinical information and imaging parameters,trying to predict the occurrence,progression,and complications of AF,thereby providing a basis for clinical decision-making.However,despite certain progress,current research still faces multiple challenges,such as data privacy,model interpretability,the accuracy and rationality of parameter selection,and the clinical operability and feasibility of data implementation.Therefore,we aim to review the latest researches of AI in AF prediction,analyze the current application status,and discuss the future development,in order to provide references and insights for further research in related fields.

Aim To study whether intravenous injec-tion of miR-129-3p mimetic(agomir)can resist bone loss caused by hind limb disuse,and to provide new i-deas for preventing bone loss in microgravity environ-ment.Methods Forty-eight C57BL/6J male mice were randomly divided into the control group(CON),tail suspension model group(TS),tail suspension+miR-129-3p agomir administration group(miRNA)and tail suspension+miR-129-3p negative sequence agomir control group(NC).The miRNA group was given 4 mg·kg-1 miR-129-3p agomir by intravenous injection into the medial canthus twice a week.The NC agomir group were consistent with those in the miR-129-3p agomir group,and the CON and TS groups were given only equal volumes of normal saline.After four weeks,all mice were sacrificed and samples were collected.Micro-CT scan of femur,three-point femur bending test,serum bone metabolism index detection,oxidative stress index detection and osteogenesis-related protein expression analysis in bone tissue were per-formed.Results After four weeks,the number of tra-becular bone in the TS group was significantly re-duced,and Tb.BMD,Tb.Th,Tb.N,Tb.BS/TV and Tb.BV/TV were significantly lower than those in the CON group(P＜0.01).While Tb.Sp TS group was significantly higher than the CON group(P＜0.05),the maximum load and flexural strength of the femur significantly decreased(P＜0.01),the content of ser-um bone formation index PINP was significantly lower than that of the CON group(P＜0.01),and the con-tent of bone resorption index CTX-I was significantly higher than that of the CON group(P＜0.01),the content of serum oxidative damage indexes 8-iso-PGF2α and 8-OHdG significantly increased(P＜0.01),and the expression of osteogenesis-related pro-teins in bone tissue markedly decreased(P＜0.01).However,the increase or decrease of all indexes in miRNA group was significantly lower than that in TS group.Conclusions miR-129-3p mimetic can signifi-cantly reduce bone loss caused by hind limb disuse.This experiment provides a new idea and method for preventing bone loss in microgravity environment.

The traditional medical quality management model has many problems,such as excessive reliance on experience,poor coordination among departments,and lagging supervision,innovating medical quality management models has become an essential issue for the high-quality development of hospitals.A tertiary Grade A general hospital built a"data element multiplier"ecological chain for medical quality management,and established a complete closed-loop management system for medical quality management under the"Internet plus"model.Finally,the mobile medical quality management platform was built.Jointly driven by"Internet plus"and"data element multiplier",the level of lean management has been significantly improved,providing practical reference for hospitals at the same level.

Objective:To explore the molecular mechanism by which adipose-derived mesenchymal stem cell exosomes (ADSC-Exos) inhibit hypertrophic scars (HS), and to identify the key functional miRNA and its downstream signaling pathway.Methods:A mouse model of hypertrophic scars was established by subcutaneous injection of bleomycin. The dorsal fibrotic modeling area was intervened with human ADSC-Exos (ADSC-Exos group), while the control group was injected with the same volume of PBS. HE and Masson staining were used to evaluate the morphological changes and collagen deposition of skin scar tissue in the two groups. Immunohistochemistry was performed to detect the expression of collagen 1 (Col-1) and α-smooth muscle actin (α-SMA). Western blot was used to determine the expression levels of key proteins in the transforming growth factor-β1 (TGF-β1)/Smad pathway (p-Smad2/3, Smad2/3). RNA sequencing datasets from the public database (GEO) were downloaded to analyze and screen differentially expressed miRNAs after ADSC-Exos treatment. In vitro cultured human hypertrophic scar fibroblasts (HSF) were transfected with miR-376b-5p mimic or inhibitor on the basis of ADSC-Exos treatment, and the expression of fibrosis markers (Col-1, α-SMA) as well as p-Smad2/3 and Smad2/3 was detected.Results:In vivo experiments showed that ADSC-Exos treatment significantly improved the fibrotic phenotype of mouse scar tissue, reduced the expression of Col-1 and α-SMA, and decreased the phosphorylation of Smad2/3 protein. Bioinformatics analysis revealed that miR-376b-5p was one of the most significantly upregulated miRNAs after ADSC-Exos treatment. In vitro experiments confirmed that overexpression of miR-376b-5p could mimic the antifibrotic effect of ADSC-Exos, significantly inhibit the expression of Col-1 and α-SMA in HSF, and reduce the phosphorylation level of Smad2/3. Specific inhibition of miR-376b-5p could effectively reverse the inhibitory effect of ADSC-Exos on the fibrotic phenotype of HSF and the phosphorylation of Smad2/3.Conclusions:This study reveals that ADSC-Exos exert their antifibrotic effect by mediating miR-376b-5p to target and inhibit the activation of the TGF-β1/Smad signaling pathway. miR-376b-5p is a key functional molecule in ADSC-Exos, and this finding provides a new potential target for the treatment of HS.

Melanoma is characterized by high malignancy, ranking the third among skin malignancies, and is associated with lack of specific treatment options and poor prognosis. Therefore, the development of effective therapies for melanoma is imperative. A critical challenge in addressing subcutaneous disease lies in overcoming the skin barrier. In this study, we engineered a microneedle (MN) system that integrates chemotherapy, photothermal therapy (PTT), and targeted therapy to enhance anti-tumor efficacy while effectively penetrating the skin barrier. In vitro studies have demonstrated that the MN drug delivery system (DDS) can effectively penetrate the stratum corneum of the skin, deliver therapeutics to subcutaneous tumor sites, and establish a drug reservoir at these locations to exert anti-tumor effects. Cellular experiments indicated that the engineered PTT chemotherapy-targeted MNs can be internalized by tumor cells, exhibiting enhanced cytotoxicity against them. In vivo pharmacological investigations revealed that the combination of PTT and chemotherapy delivered via this MN DDS produced synergistic anti-tumor effects, achieving a tumor inhibition rate of up to 98.15%. This in situ DDS minimizes involvement with other organs, significantly reducing chemotherapy-related side effects. In summary, the PTT chemotherapy-targeted MNs developed in this study demonstrate promising application potential by enhancing anti-tumor efficacy while minimizing adverse effects.

Most tumor cells and healthy neurons are at rest during G0 phase.Once the cell cycle is abnormally re-entered under certain conditions,the proliferation of tumor cells and the degenerative necrosis of neurons can be initiated.From the perspective of the cell cycle,cancer and central nervous system diseases,two seemingly different disease types,have a common pathogenesis.This type of diseases is named aberrant cell cycle diseases.As a newly discovered microRNA(miR),miR-1976 is closely related to the regulation of the cell cycle.This review summarizes the progress in the research on miR-1976 in cancer and central nervous system diseases,aiming to provide a reference for the clinical application of miR-1976 in aberrant cell cycle diseases in the future.
MicroRNAs/genetics* ; Humans ; Cell Cycle/genetics* ; Neoplasms/genetics* ; Central Nervous System Diseases/genetics*

The traditional medical quality management model has many problems,such as excessive reliance on experience,poor coordination among departments,and lagging supervision,innovating medical quality management models has become an essential issue for the high-quality development of hospitals.A tertiary Grade A general hospital built a"data element multiplier"ecological chain for medical quality management,and established a complete closed-loop management system for medical quality management under the"Internet plus"model.Finally,the mobile medical quality management platform was built.Jointly driven by"Internet plus"and"data element multiplier",the level of lean management has been significantly improved,providing practical reference for hospitals at the same level.